HIGHLIGHTS
- who: Sebastian E. Serfling from the Division of Endocrinology and Diabetes, Department of Medicine I, University Hospital Wu00fcrzburg, Wu00fcrzburg, Germany have published the Article: Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma, in the Journal: (JOURNAL)
- what: The authors aimed to assess the role of for therapeutic decision making upon restaging.
- how: The following sites of disease were identified by SSTR-PET/CT 15/23 (65.2%) subjects had lymph node and 4/23 (17.4%) lung involvement osseous disease was encountered in 10/23 (43 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.